These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 17132826)
21. 5-HT1A receptor antagonists reduce food intake and body weight by reducing total meals with no conditioned taste aversion. Dill MJ; Shaw J; Cramer J; Sindelar DK Pharmacol Biochem Behav; 2013 Nov; 112():1-8. PubMed ID: 24064183 [TBL] [Abstract][Full Text] [Related]
22. Hypothalamic cocaine- and amphetamine-regulated transcript peptide is reduced and fails to modulate feeding behavior in rats with chemically-induced mammary carcinogenesis. Nakhate KT; Kokare DM; Singru PS; Taksande AG; Kotwal SD; Subhedar NK Pharmacol Biochem Behav; 2010 Dec; 97(2):340-9. PubMed ID: 20833197 [TBL] [Abstract][Full Text] [Related]
23. Preclinical pharmacokinetic characterization of an adipose tissue-targeting monoclonal antibody in obese and non-obese animals. Rajan S; Mandikian D; Baruch A; Gelzleichter TR; Stevens D; Sonoda J; Cowan K; Boswell CA; Stefanich E MAbs; 2017; 9(8):1379-1388. PubMed ID: 28895785 [TBL] [Abstract][Full Text] [Related]
24. Modulation of urocortin-induced hypophagia and weight loss by corticotropin-releasing factor receptor 1 deficiency in mice. Bradbury MJ; McBurnie MI; Denton DA; Lee KF; Vale WW Endocrinology; 2000 Aug; 141(8):2715-24. PubMed ID: 10919255 [TBL] [Abstract][Full Text] [Related]
25. Liraglutide, leptin and their combined effects on feeding: additive intake reduction through common intracellular signalling mechanisms. Kanoski SE; Ong ZY; Fortin SM; Schlessinger ES; Grill HJ Diabetes Obes Metab; 2015 Mar; 17(3):285-93. PubMed ID: 25475828 [TBL] [Abstract][Full Text] [Related]
26. Peptide-Based Regulation of Metabolism as Related to Obesity. Bergen WG Endocrinology; 2017 Oct; 158(10):3081-3082. PubMed ID: 28977611 [TBL] [Abstract][Full Text] [Related]
27. Whey-reduced weight gain is associated with a temporary growth reduction in young mice fed a high-fat diet. Tranberg B; Madsen AN; Hansen AK; Hellgren LI J Nutr Biochem; 2015 Jan; 26(1):9-15. PubMed ID: 25315863 [TBL] [Abstract][Full Text] [Related]
28. Central interleukin-10 attenuates lipopolysaccharide-induced changes in food intake, energy expenditure and hypothalamic Fos expression. Hollis JH; Lemus M; Evetts MJ; Oldfield BJ Neuropharmacology; 2010; 58(4-5):730-8. PubMed ID: 20045008 [TBL] [Abstract][Full Text] [Related]
29. Selective estrogen receptor modulator promotes weight loss in ovariectomized female rhesus monkeys (Macaca mulatta) by decreasing food intake and increasing activity. Sullivan EL; Shearin J; Koegler FH; Cameron JL Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E759-67. PubMed ID: 22252940 [TBL] [Abstract][Full Text] [Related]
30. C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight. Mera P; Bentebibel A; López-Viñas E; Cordente AG; Gurunathan C; Sebastián D; Vázquez I; Herrero L; Ariza X; Gómez-Puertas P; Asins G; Serra D; García J; Hegardt FG Biochem Pharmacol; 2009 Mar; 77(6):1084-95. PubMed ID: 19094968 [TBL] [Abstract][Full Text] [Related]
31. Evidence that leptin-induced weight loss requires activation of both forebrain and hindbrain receptors. Harris RB Physiol Behav; 2013 Aug; 120():83-92. PubMed ID: 23911693 [TBL] [Abstract][Full Text] [Related]
32. Regulation of energy balance by the hypothalamic lipoprotein lipase regulator Angptl3. Kim HK; Shin MS; Youn BS; Kang GM; Gil SY; Lee CH; Choi JH; Lim HS; Yoo HJ; Kim MS Diabetes; 2015 Apr; 64(4):1142-53. PubMed ID: 25338813 [TBL] [Abstract][Full Text] [Related]
33. Ghrelin treatment causes increased food intake and retention of lean body mass in a rat model of cancer cachexia. DeBoer MD; Zhu XX; Levasseur P; Meguid MM; Suzuki S; Inui A; Taylor JE; Halem HA; Dong JZ; Datta R; Culler MD; Marks DL Endocrinology; 2007 Jun; 148(6):3004-12. PubMed ID: 17347304 [TBL] [Abstract][Full Text] [Related]
34. GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs. Costantini VJ; Vicentini E; Sabbatini FM; Valerio E; Lepore S; Tessari M; Sartori M; Michielin F; Melotto S; Bifone A; Pich EM; Corsi M Neuroendocrinology; 2011; 94(2):158-68. PubMed ID: 21778696 [TBL] [Abstract][Full Text] [Related]
35. MyD88 is a key mediator of anorexia, but not weight loss, induced by lipopolysaccharide and interleukin-1 beta. Ogimoto K; Harris MK; Wisse BE Endocrinology; 2006 Sep; 147(9):4445-53. PubMed ID: 16777969 [TBL] [Abstract][Full Text] [Related]
36. A novel monovalent FGFR1 antagonist: Preclinical safety profiles in rodents and non-human primates. Yu P; Knippel A; Onidi M; Paoletti A; Vigna E; Hellmann J; Esdar C Toxicol Appl Pharmacol; 2020 Nov; 406():115215. PubMed ID: 32866523 [TBL] [Abstract][Full Text] [Related]
40. Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats. Roth JD; Hughes H; Coffey T; Maier H; Trevaskis JL; Anderson CM Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1112-7. PubMed ID: 17698985 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]